Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Receptor-interacting serine/threonine-protein kinase 2 | ||
Ligand | BDBM372168 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | RIPK2 Inhibition Assay | ||
IC50 | 300±n/a nM | ||
Citation | Laufer, R; Ng, G; Brokx, R; Pauls, HW; Li, S; Mason, JM; Bray, MR RIPK2 inhibitors and method of treating cancer with same US Patent US10239881 Publication Date 3/26/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Receptor-interacting serine/threonine-protein kinase 2 | |||
Name: | Receptor-interacting serine/threonine-protein kinase 2 | ||
Synonyms: | CARDIAK | RICK | RIP2 | RIPK2 | RIPK2_HUMAN | Serine/threonine-protein kinase RIPK2 | Tyrosine-protein kinase RIPK2 | receptor-interacting serine/threonine-protein kinase 2 | ||
Type: | Protein | ||
Mol. Mass.: | 61201.30 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 540 | ||
Sequence: |
| ||
BDBM372168 | |||
n/a | |||
Name | BDBM372168 | ||
Synonyms: | (1r,4)-4-((6- (o-tolyl)- 5H-pyrrolo[3,2- d]pyrimidin-2- yl)amino) cyclohexanol | US10239881, Example A21 | US10239881, Example A22 | US10875863, Example A22 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H22N4O | ||
Mol. Mass. | 322.4042 | ||
SMILES | Cc1ccccc1-c1cc2nc(N[C@@H]3CC[C@H](O)CC3)ncc2[nH]1 |r,wU:13.13,16.17,(5.08,-2.1,;5.85,-.77,;7.39,-.77,;8.16,.56,;7.39,1.9,;5.85,1.9,;5.08,.56,;3.54,.56,;2.64,-.68,;1.17,-.21,;-.16,-.98,;-1.49,-.21,;-2.83,-.98,;-4.16,-.21,;-4.16,1.33,;-5.5,2.1,;-6.83,1.33,;-8.16,2.1,;-6.83,-.21,;-5.5,-.98,;-1.49,1.33,;-.16,2.1,;1.17,1.33,;2.64,1.81,)| | ||
Structure |